World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
112
Citations
61255
World Ranking
797
National Ranking
24

Medicine

D-Index
113
Citations
66922
World Ranking
4846
National Ranking
188

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Karen A. Gelmon is affiliated with the University of British Columbia in Canada. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics, and Molecular Biology.

Their work concentrates on key topics within cancer research, notably Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, BRCA gene mutations in cancer, Cancer-related Molecular Pathways, and Lung Cancer Research Studies.

Frequent collaborators in their research include Hope S. Rugo, Michael Gnant, Sibylle Loibl, Giuseppe Curigliano, and Miguel Martín.

Their publications feature regularly in several venues, including:

  • Journal of Clinical Oncology
  • Cancer Research
  • Annals of Oncology
  • The Breast
  • Current Oncology

Several representative papers illustrate the scope and focus of their research:

  • "Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer," 2021, New England Journal of Medicine
  • "5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)," 2020, Annals of Oncology
  • "Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up," 2023, Annals of Oncology
  • "Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial," 2020, Journal of Clinical Oncology
  • "Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer," 2022, Annals of Oncology

Best Publications

  • Palbociclib and Letrozole in Advanced Breast Cancer

    Richard S. Finn;Miguel Martin;Hope S. Rugo;Stephen Jones

  • Metastatic Behavior of Breast Cancer Subtypes

    Hagen Kennecke;Rinat Yerushalmi;Ryan Woods;Maggie Chon U. Cheang

  • The clonal and mutational evolution spectrum of primary triple-negative breast cancers

    Sohrab P. Shah;Andrew Roth;Rodrigo Goya;Arusha Oloumi

  • 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

    Ian Smith;Marion Procter;Richard D Gelber;Sébastien Guillaume

  • 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

    F. Cardoso;A. Costa;E. Senkus;M. Aapro

  • Breast Cancer Subtypes and the Risk of Local and Regional Relapse

    K. David Voduc;Maggie C.U. Cheang;Scott Tyldesley;Karen Gelmon

  • Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

    Karen A Gelmon;Marc Tischkowitz;Helen Mackay;Kenneth Swenerton

  • Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

    Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks

  • Ki67 in breast cancer: prognostic and predictive potential

    Rinat Yerushalmi;Ryan Woods;Peter M Ravdin;Malcolm M Hayes

  • Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled Trial

    Kerry S. Courneya;Roanne J. Segal;John R. Mackey;Karen Gelmon

  • Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

    Sohrab P. Shah;Ryan D. Morin;Jaswinder Khattra;Leah Prentice

  • Regional Nodal Irradiation in Early-Stage Breast Cancer

    Timothy J. Whelan;Ivo A. Olivotto;Wendy R. Parulekar;Ida Ackerman

  • Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial

    Joseph Ragaz;Ivo A. Olivotto;John J. Spinelli;Norman Phillips

  • Exemestane for Breast-Cancer Prevention in Postmenopausal Women

    Paul E. Goss;James N. Ingle;José E. Alés-Martínez;Angela M. Cheung

  • Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

    Andrew N.J. Tutt;Judy E. Garber;Bella Kaufman;Giuseppe Viale

  • Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.

    Rashmi K Murthy;Sherene Loi;Alicia Okines;Elisavet Paplomata

  • Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy

    José Baselga;Karen A. Gelmon;Shailendra Verma;Andrew Wardley

  • ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

    F. Cardoso;A. Costa;L. Norton;E. Senkus

  • Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial

    Edith A. Perez;Vera J. Suman;Nancy E. Davidson;George W. Sledge

  • Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

    Aleix Prat;Maggie Chon U. Cheang;Miguel Martín;Joel S. Parker

Frequent Co-Authors

Kathleen I. Pritchard
Kathleen I. Pritchard University of Toronto
David G. Huntsman
David G. Huntsman University of British Columbia
John R. Mackey
John R. Mackey University of Alberta
Marco A. Marra
Marco A. Marra University of British Columbia
Steven J.M. Jones
Steven J.M. Jones University of British Columbia
Hope S. Rugo
Hope S. Rugo University of California, San Francisco
Timothy J. Whelan
Timothy J. Whelan McMaster University
Torsten O. Nielsen
Torsten O. Nielsen University of British Columbia
Véronique Diéras
Véronique Diéras Institute Curie
Samuel Aparicio
Samuel Aparicio University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA but want to explore different healthcare career pathways, there are several affordable online degree options to consider. Programs such as an online healthcare administration degree can prepare you for leadership roles in hospitals and clinics, focusing on organizational and managerial skills rather than direct patient care.

For those interested in advancing their credentials, there are also cheap mha programs available online, which can open doors to higher-level administrative positions and greater earning potential.

If nursing is your passion, pursuing cheap dnp online programs can move you toward top clinical and teaching positions, equipping you with the expertise to influence healthcare outcomes at the highest level.

Pharmacists looking for flexibility might consider a 3-year online pharmd program, combining rigorous training with online convenience.

These alternatives offer diverse routes into the healthcare field—each providing unique career opportunities while allowing you to study online and potentially save on costs.

Best Scientists Citing Karen A. Gelmon

Trending Scientists

Recently Published Articles